Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

16.02 -0.18 (-1.08%)
Streaming Delayed Price Updated: 10:49 AM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Fulgent Genetics, Inc. Common Stock (FLGT) Q2 2021 Earnings Call Transcript ↗
FLGT earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Fulgent Genetics Q2 Earnings ↗
Shares of Fulgent Genetics (NASDAQ:FLGT) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 1400.00% year... 
Via Benzinga
News headline image
Fulgent Genetics Reports Second Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics and Helio Health Announce Strategic Partnership to Commercialize Early Cancer Detection Tests
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
While You're Waiting For That Elusive Silver Squeeze... ↗
You may be missing an actual squeeze elsewhere. 
Via Talk Markets
News headline image
AMC Goes Parabolic ↗
Our top name from April was up 568% as of Wednesday's close. Looking for the next short squeeze candidate. 
Via Talk Markets
News headline image
Fulgent Genetics Announces Acquisition of CSI Laboratories
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Why Shares of Fulgent Genetics Rose 77% in the First Half of 2021 ↗
The stock has traded with the ebbs and flows of COVID cases, but its testing has consistently delivered for its impressive list of customers. 
Via The Motley Fool
News headline image
3 Things About Fulgent Genetics That Smart Investors Know ↗
Few companies had bigger tailwinds from COVID-19. What comes next could be even more exciting. 
Via The Motley Fool
News headline image
5 Stocks to Own for the Surge in Coronavirus Variants ↗
Despite easing restrictions, COVID is going to be around a lot longer than many think. 
Via The Motley Fool
News headline image
3 Stocks I'd Buy if the Market Crashes ↗
A steep sell-off is required for these stocks to become bargain buys. 
Via The Motley Fool
News headline image
Is It Too Late to Buy Fulgent Genetics Stock? ↗
All is not lost for this COVID-19 testing company. 
Via The Motley Fool
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
3 Reasons I Just Bought Fulgent Genetics Stock ↗
Ongoing COVID-19 testing and deals in the core business could keep growth high for longer than many think. 
Via The Motley Fool
News headline image
2 Stocks That Are More Likely to Double Your Money Than Dogecoin ↗
Wall Street is nervous, but these companies see growth beyond the pandemic. 
Via The Motley Fool
News headline image
From Short Squeezes To Silver ↗
Updates on our two recent heavily-shorted top names; a shift to silver. 
Via Talk Markets
News headline image
What Does Life After COVID Look Like for Fulgent Genetics? ↗
Fulgent rode on a wave of COVID revenue. What comes next could be pretty special. 
Via The Motley Fool
News headline image
AMC Goes Parabolic: Looking For The Next Short Squeeze Candidate. ↗
Moviegoers at an AMC theater waiting for a showing of the last Fast & Furious movie (photo via author). Crypto Crabs While AMC Skyrockets A point we made last week... 
Via Benzinga
News headline image
8 Stocks With The Highest Short Percent Of Float Right Now ↗
Traders often look at short interest to get a sense of how many people are bearish on a stock and how strong the possibility of a short squeeze is. But simply looking at the size... 
Via Benzinga
News headline image
Step Aside AMC: Here Are The Most Shorted Stocks Right Now ↗
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
News headline image
How Long Will Fulgent Genetics Benefit From the Pandemic? ↗
Genetic testing for the coronavirus is slowing. 
Via The Motley Fool
News headline image
Forget Dogecoin -- Buy These 3 Growth Stocks Instead ↗
They are all coming off some impressive quarterly results. 
Via The Motley Fool
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
Week In Review: GenScript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse ↗
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the... 
Via Talk Markets
News headline image
What Are Investors Thinking About Fulgent Genetics? ↗
Hint: It has something to do with COVID-19. 
Via The Motley Fool
News headline image
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Why Investors Loved Fulgent Genetics' Q1 Results ↗
More than 4,500% revenue growth gave Wall Street and shareholders something to cheer about. 
Via The Motley Fool
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.